27 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
invented the technologies we use today in our research and product development and who continue to drive innovation. Genome-Editing Landscape … trade secrets, know-how, continuing technological innovation and potential in- licensing opportunities to develop and maintain our competitive
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
of the scientists who invented the technologies we use today in our research and product development and who continue to drive innovation. Genome-Editing … , and United Kingdom. Table of Contents 30
Furthermore, we rely upon trade secrets, know-how, continuing technological innovation and potential in- licensing
DEFA14A
b12lmckjwf3nh3lj
11 Aug 22
Additional proxy soliciting materials
4:06pm
10-K
2r7jafg31syzja86ijd
21 Mar 22
Annual report
4:19pm
8-K
EX-99.1
0jbie
8 Nov 21
Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer
9:10am
8-K
EX-99.1
give4uf36z0 om
29 Sep 21
Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng
4:15pm
424B4
an87yjmcwarmthrjbqte
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
axxtyma6y
19 Jul 21
IPO registration (amended)
6:09am
S-1
EX-4.1
22khllt20anr
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.62
1ixo7f0kqfcva
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.59
k7qe8uscmdl2vmzdhi6z
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.20
2vw7jg441l wtxx
1 Jul 21
IPO registration
4:05pm
S-1
qfagkjqw6i8
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.60
3vd ylykm2
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.16
doq9ko7mx7d
1 Jul 21
IPO registration
4:05pm
DRS/A
px22y8m k6d
11 Jun 21
Draft registration statement (amended)
12:00am